Lymph Node Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Lymph Node Neoplasm

cancer family

Identifier: CI-CAN-00000222
Entity page: /cancer/lymph-node-neoplasm ↗
Edges: 10

Neighbours: 2 drugs8 trials
Drawn: 10 of 10 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Lymph Node Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived2 of 2
→ investigated in trials for	CAPOX Regimen 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Nivolumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants	—	—

Lymph Node Neoplasm studied in …STUDIED_INderived8 of 8
→ studied in	NCT07538960not yet recruiting Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica. · condition mapped ALIAS · 8 trials mapped (2 active)	—	—	Malignant Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06527027NA · recruiting LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT03618641Phase 2 · completed CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease · condition mapped ALIAS · 8 trials mapped (2 active)	—	—	Malignant Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT04553744withdrawn Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons · condition mapped ALIAS · 8 trials mapped (2 active)	—	—	Malignant Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT05287880unknown Quantitative Analysis of 18F-FAPI Dynamic PET/CT for Accurate Differential Diagnosis of MLN of ESCC · condition mapped ONTOLOGY_EXACT · 8 trials mapped (2 active)	—	—	Benign Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT01815333NA · completed Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging · condition mapped ALIAS · 8 trials mapped (2 active)	—	—	Malignant Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02298010completed Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial · condition mapped ALIAS · 8 trials mapped (2 active)	—	—	Malignant Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT02555592unknown Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic Level · condition mapped ALIAS · 8 trials mapped (2 active)	—	—	Malignant Lymph Node Neoplasm	1	Observed	clinicaltrials	graph →